HALECEF 1G / 1.5G / 2G / 3G

bt_bb_section_bottom_section_coverage_image
halecef-1g-inj
HALECEF 1.5g
halecef-2g-inj
halecef-3g-inj

HALECEF 1G / 1.5G / 2G / 3G

Cefoperazone & Sulbactam (I.V/I.M) Injection 

Cefoperazone and Sulbactam: A Powerful Combination

Cefoperazone is a third-generation cephalosporin antibiotic, and sulbactam is a beta-lactamase inhibitor. When combined, they form a potent antibiotic combination that is effective against a wide range of gram-negative bacteria, including those that are resistant to other antibiotics. 

Advantages of Cefoperazone and Sulbactam

  • Broad Spectrum: Effective against both gram-positive and gram-negative bacteria.
  • Resistant Strains: Can be used to treat infections caused by resistant strains, such as extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.
  • Cost-Effective: Often considered a cheaper alternative to meropenem, especially in countries with limited healthcare resources.
  • Synergistic Effect: The combination of cefoperazone and sulbactam enhances the antibiotic’s activity and helps to overcome bacterial resistance. 

Indications for Cefoperazone and Sulbactam

  • Respiratory Tract Infections: Pneumonia, bronchitis
  • Intra-Abdominal Infections: Peritonitis, abscesses
  • Urinary Tract Infections: Cystitis, pyelonephritis
  • Skin and Soft Tissue Infections: Cellulitis, abscesses
  • Septicemia: Bloodstream infections
  • Gynecological Infections: Pelvic inflammatory disease, endometritis
  • Meningitis: Inflammation of the meninges (the protective membranes surrounding the brain and spinal cord)
  • Bone and Joint Infections: Osteomyelitis, arthritis
  • Infections in Neutropenic Patients: Patients with low white blood cell counts

Dosage

The dosage of cefoperazone and sulbactam varies depending on the severity of the infection, the patient’s weight, and renal function. Consult a healthcare professional for specific dosing instructions. 

General dosage guidelines:

  • Adults: 2-4 grams per day in divided doses.

Precautions

  • Hypersensitivity: Do not use if allergic to cephalosporins or penicillins.
  • Renal Impairment: Dosage adjustment may be necessary in patients with kidney problems.
  • Bleeding: May increase the risk of bleeding in patients taking certain medications (e.g., anticoagulants).
  • Superinfection: Can lead to overgrowth of resistant bacteria.

Disclaimer: This information is for general knowledge only and should not be considered medical advice. Always consult with a healthcare professional for personalized guidance.

https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_04.png
halecef-1g-inj
HALECEF 1.5g
halecef-2g-inj
halecef-3g-inj
https://www.larivinpharma.com/wp-content/uploads/2020/04/small_blue_triangle.png
https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_01.png
https://www.larivinpharma.com/wp-content/uploads/2023/03/larivin-pharma-footer-icon-160x160.png
No.32, First Floor, Varadharaja Swamy Nagar, Sri Krishna Nagar, Maduravoyal, Chennai, Tamil Nadu 600095

© 2023 Larivin Pharma Private Limited. All rights reserved